Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data
Source: SeekingAlpha
2026-05-20 13:21:11 ET
The last time I spoke about Wave Life Sciences ( WVE ), it was in a Seeking Alpha article entitled " Wave Life Sciences: Potential For Accelerated Approval Pathway with WVE-N531 ." With respect to this article, I mentioned the company's advancement of WVE-N531 for potential Accelerated Approval for the treatment of patients with Duchenne Muscular Dystrophy [DMD] amenable to exon 53 skipping....
Read the full article on Seeking Alpha
For further details see:
Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data
Wave Life Sciences Ltd.
NASDAQ: WVE
WVE Trading
-5.93% G/L:
$5.795 Last:
1,128,100 Volume:
$6.08 Open:
WVE Latest News
WVE Stock Data
$2,455,817,603
74,781,401
10.3%
63
N/A
Biotechnology & Life Sciences
Healthcare
SG
